#China #Qingdao #Global Ranking #Life Science #Haier Biomedical

Haier Biomedical's Remarkable Achievement in Life Science Lab Equipment

In a significant milestone for Haier Biomedical, the company has been ranked as the leading Chinese brand in global life science laboratory equipment sales, as well as the top brand in overseas sales, according to Euromonitor International's 2025 report. This outstanding achievement not only reflects Haier Biomedical's robust position in a competitive global market but also highlights the effectiveness of its strategic expansion efforts over the past few years, resulting in a compound annual growth rate (CAGR) exceeding 20%.

Euromonitor International is recognized worldwide for its independent market research, making its rankings a valuable benchmark for industry stakeholders. The recognition from this esteemed organization solidifies Haier Biomedical's market leadership within the life sciences laboratory equipment sector, offering credibility to potential partners and clients who prioritize reliability and regulatory compliance when selecting suppliers.

The foundation for Haier Biomedical's international presence was built through targeted collaborations with esteemed organizations such as UNICEF and the World Health Organization. By addressing specific unmet needs, particularly in solar-powered vaccine storage solutions, the company has positioned itself as a trusted partner in public health. Today, Haier Biomedical has successfully established a distribution network that spans 160 countries, supported by over 800 active dealer relationships, ensuring its products reach laboratories that require advanced scientific equipment.

Currently, Haier Biomedical is focused on enhancing its operational capabilities worldwide. The company has set up regional warehousing, sales, marketing, product planning, and research and development (R&D) centers in key regions, including the UK, Italy, and Japan. Each of these centers specializes in product lines that cater to specific laboratory needs, from centrifuges to biosafety equipment. This localized approach allows for personalized service and support, particularly for laboratories that need assistance with Good Manufacturing Practice (GMP) compliance, air safety, and sample purification.

The company's innovative Ultra Energy series has dominated the US Energy Star rankings across its category, further cementing Haier Biomedical's reputation in the pharmaceutical sector. The company is integral to the supply chains of several leading pharmaceutical firms operating in major markets such as Switzerland, Germany, Denmark, Italy, Singapore, the US, Israel, and India.

In recent performance reports, Haier Biomedical has noted impressive growth in several regions. In the first quarter of 2026 alone, revenue surged by more than 50% in Germany, Australia, and Canada, with some markets in Eastern Europe and South Asia experiencing a staggering 100% year-on-year growth. Centrifuge and incubator sales have doubled, signaling strong demand for high-quality laboratory equipment.

As Haier Biomedical looks to the future, it plans to further deepen its investments and expand its product range. The company envisions helping biopharmaceutical and life sciences laboratories improve both efficiency and sustainability through integrated tools and intelligent productivity platforms. This commitment to innovation and regional empowerment positions Haier Biomedical at the forefront of the laboratory equipment industry, ready to lead the global market.

To learn more about Haier Biomedical’s offerings and their impact on laboratory efficiency, visit their official website Haier Biomedical.